AI assistant
Tempest Therapeutics, Inc. — Director's Dealing 2016
Jan 6, 2016
34632_dirs_2016-01-05_930b145f-ce8a-4a39-b838-088f8438983b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2015-12-31
Reporting Person: Dipp Michelle (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-31 | Common Stock | A | 4635 | $0.00 | Acquired | 990136 | Direct |
| 2015-12-31 | Common Stock | F | 1507 | $9.77 | Disposed | 988629 | Direct |
| 2015-12-31 | Common Stock | F | 1256 | $9.77 | Disposed | 987373 | Direct |
Footnotes
F1: Represents the vesting of 60% of the performance conditions of the first annual installment of the restricted stock units ("RSUs") granted to the Reporting Person in December 2014.
F2: Shares withheld by the Registrant to satisfy minimum statutory withholding requirements upon vesting of time-based RSUs. Withheld shares are not sold.
F3: Shares withheld by the Registrant to satisfy minimum statutory withholding requirements upon vesting of time-based RSUs. Withheld shares are not sold.
F4: Represents 971,921 shares of common stock and 15,452 RSUs.